June 8th - $Kiora Pharmaceuticals (KPRX.US)$ is about to implement a 1-for-9 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from June 11th, 2024.
$Kiora Pharmaceuticals (KPRX.US)$ rose 8.8% and closed at $0.47 on June 7th with a turnover of $299.12K. $Kiora Pharmaceuticals (KPRX.US)$ now has a total market capitalization of $12.34 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.